| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/PHAR.1790 |
| P698 | PubMed publication ID | 27332671 |
| P2093 | author name string | Paul Balmer | |
| Ashesh Gandhi | |||
| Bruce Atkinson | |||
| P2860 | cites work | Meningococcal carriage by age: a systematic review and meta-analysis | Q33746085 |
| Updated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: effectiveness, validation of serological correlates of protection, and modeling predictions of the duration of herd immunity | Q33825722 | ||
| Phase I/II, open-label trial of safety and immunogenicity of meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine in human immunodeficiency virus-infected adolescents | Q33844571 | ||
| Assessing the risk of laboratory-acquired meningococcal disease | Q34042370 | ||
| Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story | Q34093820 | ||
| Immunogenicity and safety of a CRM-conjugated meningococcal ACWY vaccine administered concomitantly with routine vaccines starting at 2 months of age. | Q34290891 | ||
| Epidemic meningitis, meningococcaemia, and Neisseria meningitidis | Q34644525 | ||
| Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis | Q34716729 | ||
| Immunogenicity and safety of a multicomponent meningococcal serogroup B vaccine and a quadrivalent meningococcal CRM197 conjugate vaccine against serogroups A, C, W-135, and Y in adults who are at increased risk for occupational exposure to meningoc | Q34739055 | ||
| First Use of a Serogroup B Meningococcal Vaccine in the US in Response to a University Outbreak | Q36206141 | ||
| Trends in meningococcal disease in the United States military, 1971-2010. | Q36221304 | ||
| Human immunity to the meningococcus. II. Development of natural immunity | Q36269758 | ||
| Increased case-fatality rate associated with outbreaks of Neisseria meningitidis infection, compared with sporadic meningococcal disease, in the United States, 1994-2002. | Q36499084 | ||
| Epidemiology of infant meningococcal disease in the United States, 2006-2012 | Q36715529 | ||
| The changing epidemiology of meningococcal disease in North America 1945-2010. | Q36887966 | ||
| Comparison of the Safety and Immunogenicity of a Novel Quadrivalent Meningococcal ACWY-Tetanus Toxoid Conjugate Vaccine and a Marketed Quadrivalent Meningococcal ACWY-Diphtheria Toxoid Conjugate Vaccine in Healthy Individuals 10-25 Years of Age. | Q37600163 | ||
| Epidemiology and meningococcal serogroup distribution in the United States | Q37761235 | ||
| Meningococcal disease: clinical presentation and sequelae. | Q38011313 | ||
| Phase III comparison of an investigational quadrivalent meningococcal conjugate vaccine with the licensed meningococcal ACWY conjugate vaccine in adolescents | Q38381404 | ||
| Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: implications for prevention of meningococcal disease | Q39920363 | ||
| Use of Serogroup B Meningococcal Vaccines in Adolescents and Young Adults: Recommendations of the Advisory Committee on Immunization Practices, 2015. | Q40402876 | ||
| A comparative evaluation of two investigational meningococcal ABCWY vaccine formulations: Results of a phase 2 randomized, controlled trial. | Q41400370 | ||
| Changes in the Population Structure of Invasive Neisseria meningitidis in the United States After Quadrivalent Meningococcal Conjugate Vaccine Licensure | Q41565209 | ||
| Elevated risk for invasive meningococcal disease among persons with HIV. | Q42259273 | ||
| Prolonged university outbreak of meningococcal disease associated with a serogroup B strain rarely seen in the United States | Q42266218 | ||
| Meningococcal disease in US military personnel before and after adoption of conjugate vaccine | Q43126476 | ||
| Invasive meningococcal disease among university undergraduates: association with universities providing relatively large amounts of catered hall accommodation | Q44531585 | ||
| Risk factors for meningococcal disease in college students | Q44937042 | ||
| Seroprevalence and placental transmission of maternal antibodies specific for Neisseria meningitidis Serogroups A, C, Y and W135 and influence of maternal antibodies on the immune response to a primary course of MenACWY-CRM vaccine in the United Kin | Q50907461 | ||
| The Global Meningococcal Initiative: recommendations for reducing the global burden of meningococcal disease. | Q53157734 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | outbreak prevention | Q96043460 |
| disease prevention | Q106807541 | ||
| P304 | page(s) | 880-892 | |
| P577 | publication date | 2016-06-22 | |
| P1433 | published in | Pharmacotherapy | Q7180800 |
| P1476 | title | History of Meningococcal Outbreaks in the United States: Implications for Vaccination and Disease Prevention | |
| P478 | volume | 36 |
| Q52332492 | Distinct evolutionary patterns of Neisseria meningitidis serogroup B disease outbreaks at two universities in the USA. |
| Q91620656 | Eculizumab in paroxysmal nocturnal haemoglobinuria and atypical haemolytic uraemic syndrome: 10-year pharmacovigilance analysis |
| Q92193207 | Epidemiologic Trends, Global Shifts in Meningococcal Vaccination Guidelines, and Data Supporting the Use of MenACWY-TT Vaccine: A Review |
| Q93271548 | Experience implementing a university-based mass immunization program in response to a meningococcal B outbreak |
| Q89771036 | Experts' opinion for improving global adolescent vaccination rates: a call to action |
| Q55303290 | Impact of meningococcal vaccination on carriage and disease transmission: A review of the literature. |
| Q57055712 | Meningococcal disease in adolescents and young adults: a review of the rationale for prevention through vaccination |
| Q37669413 | Meningococcal serogroup B vaccines: Estimating breadth of coverage |
| Q97567758 | Parental awareness and utilization of meningococcal serogroup B vaccines in the United States |
| Q93051919 | Structural Basis for Evasion of Nutritional Immunity by the Pathogenic Neisseriae |
| Q45070397 | Subversion of Nutritional Immunity by the Pathogenic Neisseriae |
| Q54964676 | Vaccination strategies for the prevention of meningococcal disease. |
Search more.